Bin trotzdem oder gerade darum hier eingestiegen 14,19 EUR und schon fett im Minus!
|48 Beiträge ausgeblendet.|| |
Analyst senkt das Kursziel von 8 auf 3$
hab heute direkt nachgelegt...
auch in der Opiat-Geschichte könnte sich das Blatt wenden bzw. alles nicht ganz so übertrieben kommen, wie das so mancher Schreiberling scharzmalt:
"In his 27-page order dismissing North Dakota's lawsuit, Hill (das ist der Name des Richters) maintained that Purdue cannot control how its customers use their drugs. "Purdue cannot control how doctors prescribe its products, and it certainly cannot control how individual patients use and respond to its products, regardless of any warning or instruction Purdue may give," Hill wrote in his order.
Hill's dismissal was a critical win for Purdue, the company said. "The May 2019 decision by the North Dakota court to dismiss all the claims filed by the attorney general of North Dakota against Purdue is a significant legal victory for the company that has potential far-reaching ramifications for both the state lawsuits filed against Purdue and for the claims pending in the multi-district litigation (MDL)," the company said.
"We expect that when judges look at these cases and impartially apply the law, they will also dismiss on grounds of federal preemption," the company said. "As explained by the court in North Dakota in May 2019 and again in July 2019, the FDA specifically disagreed with the states' contention that Purdue made false and misleading statements about certain benefits of OxyContin.
Endo meldet Zahlen für Q2/19